Welcome to LookChem.com Sign In|Join Free
  • or
(S)-(+)-1-[4,4-bis(4-fluorophenyl)butyl]-4-[2-hydroxy-3-(phenylamino)propyl]piperazine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

195455-99-3

Post Buying Request

195455-99-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

195455-99-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 195455-99-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,5,4,5 and 5 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 195455-99:
(8*1)+(7*9)+(6*5)+(5*4)+(4*5)+(3*5)+(2*9)+(1*9)=183
183 % 10 = 3
So 195455-99-3 is a valid CAS Registry Number.

195455-99-3Downstream Products

195455-99-3Relevant academic research and scientific papers

Efficient asymmetric syntheses, determination of absolute configurations and biological activities of 1-[4,4-bis(4-fluorophenyl)butyl]-4-[2-hydroxy-3- (phenylamino)propyl]piperazine as a novel potent dopamine uptake inhibitor in the central nervous system

Kimura, Makoto,Masuda, Tomoko,Yamada, Koji,Mitani, Masaki,Kubota, Nobuo,Kawakatsu, Nobuyuki,Kishii, Kenichi,Inazu, Masato,Kiuchi, Yuji,Oguchi, Katsuji,Namiki, Takayuki

, p. 3069 - 3078 (2007/10/03)

An efficient asymmetric synthesis of the chiral N-(3-chloro-2- hydroxypropyl)anilines (2a and 2b) was achieved through the regioselective ring-opening reaction of chiral epichlorohydrin with aniline. This was applied to an asymmetric synthesis of the enantiomers of 1-[4,4-bis(4-fluorophenyl) butyl]-4-[2-hydroxy-3-(phenylamino)propyl]piperazine 1 as a novel potent dopamine uptake inhibitor. Both enantiomers as trihydrochlorides, 4a·3HCl and 4b·3HCl, could be synthesized in good total yields and optical purities of 100% ee in three steps synthesis, respectively. The absolute configurations of 4a·3HCl and 4b·3HCl were determined using the modified Mosher's method with the related compounds, the intermediates (2a and 2b) and the free bases (4a and 4b). The analytical results indicated that 4a·3HCl and 4b·3HCl have the (S)- and (R)-configuration, respectively, and a series of reactions to provide them proceeded without the apparent influence on the stereochemistry at the chiral centers. In in vitro pharmacological evaluations, 4a·3HCl and 4b·3HCl showed potent dopamine transporter binding affinities, high dopamine, moderate serotonin, and weak norepinephrine uptake inhibitory activities, and 4a·3HCl exhibited a more potent and selective dopamine uptake inhibition over the serotonin or norepinephrine uptake inhibition as compared with 4b·3HCl. An ex vivo evaluation revealed that the oral administrations of both enantiomers at a dose of 30mg/kg in rats displayed apparent dopamine uptake inhibitory activities and 4a·3HCl had a stronger tendency to inhibit dopamine uptake compared with 4b·3HCl.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 195455-99-3